Delivery Order SPE2DX22D0010-SPE2D825FGR87
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $67,832.46, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta ER Tabs 27mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $8,217.60 with an ultimate completion date of August 12, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order has a ceiling value of $9,502.20 and is scheduled for completion by July 29, 2025. The award was made on a competitive basis with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a $5,190.36 delivery order to AmerisourceBergen Drug Corp for Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, issued on October 29, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by October 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the...
- The U.S. Defense Department's Medical Supply Chain awarded a $45,744.59 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger indefinite delivery contract vehicle. Performance will be executed from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $11,257.85. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg, with a ceiling value of $1,849.39. This firm fixed-price, non-set-aside contract was awarded on June 6, 2025, with an ultimate completion date of June 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order serves as a child contract under the company's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,846.16 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on September 29, 2025, with completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,786.94 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FGR87Delivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate product commonly used for attention deficit hyperactivity disorder treatment. This firm fixed-price delivery order, valued at $17,783.70 with an ultimate completion date of July 2, 2025, was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contracting presence with the Defense Logistics Agency, supporting Defense Health Agency operations and other military healthcare programs. The company's contract portfolio demonstrates extensive experience delivering a broad range of pharmaceutical products across multiple therapeutic domains on firm fixed-price terms, positioning it as a critical vendor for federal medical procurement. This delivery order represents one of numerous competitive awards the contractor has received, reflecting its capability to meet stringent federal procurement requirements and support military healthcare logistics worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 7/1/25 |